VIPR1 Antikörper (AA 34-146)

Produktnummer ABIN5014524

Produktdetails anti-VIPR1 Antikörper

Target: VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))

Bindungsspezifität: AA 34-146

Reaktivität: Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser VIPR1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Verwendungszweck: Polyclonal Antibody to Vasoactive Intestinal Peptide Receptor 1 (VIPR1)

Spezifität: The antibody is a rabbit polyclonal antibody raised against VIPR1. It has been selected for its ability to recognize VIPR1 in immunohistochemical staining and western blotting.

Kreuzreaktivität: Maus

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: VIPR1 (Gln34-Gly146)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.2-2 μg/mL,1:250-2500 Immunohistochemistry: 5-20 μg/mL,1:25-100 Immunocytochemistry: 5-20 μg/mL,1:25-100 Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 500 μg/mL

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Konservierungsmittel: Sodium azide

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu VIPR1

Target: VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))

Andere Bezeichnung: VIPR1 (VIPR1 Produkte)

Hintergrund: HVR1, PACAP-R-2, RDC1, VAPC1, VIPR, VIRG, VPAC1, Pituitary adenylate cyclase-activating polypeptide type II receptor